Back
Perspective Therapeutics Stock Price Chart
2025 Gold Forecast: A Perfect Storm for Demand
Discover our Gold Price Outlook for 2025--FREE--here
Sell
31
CATX
Perspective Therapeutics
Last Price:
$3.23
Seasonality Move:
41.25%
7 Day Trial
ALL ACCESS PASS
$
7
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CATX is experiencing buying pressure, which is a positive indicator for future bullish movement.
Perspective Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 3.14 | Buy |
| 20-day SMA: | 3.58 | Sell |
| 50-day SMA: | 7.6 | Sell |
| 200-day SMA: | 12.12 | Sell |
| 8-day EMA: | 3.19 | Buy |
| 20-day EMA: | 4.02 | Sell |
| 50-day EMA: | 6.68 | Sell |
| 200-day EMA: | 9.88 | Sell |
Perspective Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -1.22 | Sell |
| Relative Strength Index (14 RSI): | 28.01 | Sell |
| Chaikin Money Flow: | 344055 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (2.89 - 4.69) | Sell |
| Bollinger Bands (100): | (6.4 - 14.96) | Sell |
Perspective Therapeutics Technical Analysis
| Dec 11 | Dec 12 | Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 20 | Dec 23 | Dec 24 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | 23 | 24 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Perspective Therapeutics Stock
Is Perspective Therapeutics Stock a Buy?
-
Perspective Therapeutics share price is 3.25 while CATX 8-day simple moving average is 3.14, which is a Buy signal.
-
The stock price of CATX is 3.25 while Perspective Therapeutics 20-day SMA is 3.58, which makes it a Sell.
-
Perspective Therapeutics 50-day simple moving average is 7.60 while CATX share price is 3.25, making it a Sell technically.
-
CATX stock price is 3.25 and Perspective Therapeutics 200-day simple moving average is 12.12, creating a Sell signal.
CATX Technical Analysis vs Fundamental Analysis
Sell
31
Perspective Therapeutics (CATX)
is a Sell
Is Perspective Therapeutics a Buy or a Sell?
-
Perspective Therapeutics stock is rated a SellThe current Perspective Therapeutics [CATX] share price is $3.25. The Score for CATX is 31, which is 38% below its historic median score of 50, and infers higher risk than normal.
Perspective Therapeutics Stock Info
Market Cap:
219.7M
Price in USD:
3.25
Share Volume:
502.8K
Perspective Therapeutics 52-Week Range
52-Week High:
19.05
52-Week Low:
2.70
Sell
31
Perspective Therapeutics (CATX)
is a Sell
Perspective Therapeutics Share Price Forecast
-
What is the Perspective Therapeutics stock price today?The Perspective Therapeutics stock price is 3.25 USD today.
-
Will CATX stock go up or go down?Perspective Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is Perspective Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Perspective Therapeutics is overvalued.
Is Perspective Therapeutics Stock a Buy?
-
Perspective Therapeutics share price is 3.25 while CATX 8-day exponential moving average is 3.19, which is a Buy signal.
-
The stock price of CATX is 3.25 while Perspective Therapeutics 20-day EMA is 4.02, which makes it a Sell.
-
Perspective Therapeutics 50-day exponential moving average is 6.68 while CATX share price is 3.25, making it a Sell technically.
-
CATX stock price is 3.25 and Perspective Therapeutics 200-day simple moving average is 9.88, creating a Sell signal.
Fundamental Analysis of Perspective Therapeutics
Is Perspective Therapeutics a good investment?
-
Analysts estimate an earnings decrease this quarter of $0.16 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.79 per share, and a decrease next year of $0.49 per share.
Technical Analysis of Perspective Therapeutics
Should I short Perspective Therapeutics stock?
-
CATX Moving Average Covergence Divergence (MACD) indicator is -1.22, suggesting Perspective Therapeutics is a Sell
-
Perspective Therapeutics Relative Strength Index (RSI) is 28.01, which suggest Perspective Therapeutics is oversold
-
The Bollinger Bands (25) for Perspective Therapeutics is (2.89 - 4.69), which suggest Perspective Therapeutics is a Sell
-
The Bollinger Bands (100) for Perspective Therapeutics is (6.4 - 14.96), which suggest Perspective Therapeutics is a Sell
* Perspective Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.